Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers
Authors:
- Howard S. CuckleHCHoward S. Cuckle
- John C. HobbinsJHJohn C. Hobbins
- Fergal D. MaloneFMFergal D. Malone
- Michael A. BelfortMBMichael A. Belfort
- David A. NybergDNDavid A. Nyberg
- Christine H. ComstockCCChristine H. Comstock
- George R. SaadeGSGeorge R. Saade
- Keith A. EddlemanKEKeith A. Eddleman
- Peer DarPDPeer Dar
- Sabrina D. CraigoSCSabrina D. Craigo
- Ilan E. Timor-TritschITIlan E. Timor-Tritsch
- 1 September 2008
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 199 (3) , 290.e1-290.e6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prediction and Prevention of Recurrent StillbirthObstetrics & Gynecology, 2007
- Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal deathBJOG: An International Journal of Obstetrics & Gynaecology, 2007
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal deathUltrasound in Obstetrics & Gynecology, 2006
- Maternal age and the risk of stillbirth throughout pregnancy in the United StatesAmerican Journal of Obstetrics and Gynecology, 2006
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- Pregnancy-Associated Plasma Protein A, Free β-hCG, Nuchal Translucency, and Risk of Pregnancy LossObstetrics & Gynecology, 2004
- Unexplained elevated maternal serum α-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomesAmerican Journal of Obstetrics and Gynecology, 2003
- Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcomeObstetrics & Gynecology, 2001
- Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcomePrenatal Diagnosis, 2000